The last session of the 4th Digital Rheumatology Day focused on a pitch competition for innovative digital solutions. Three companies were invited to present their 3-minute pitch videos and to convince the audience on how their solution can improve quality of care in...
There is growing evidence that digital therapeutics can effectively improve the course of diseases. Mostly chronic disorders are addressed by behaviour change or exercise programs. In Germany, so-called DIGAs (Digitale Gesundheits Anwendung = Digital Health...
Background: Systemic lupus erythematosus (SLE), a systemic autoimmune disease with no known cure, remains poorly understood and patients suffer from many gaps in care. Recent work has suggested that dietary and other lifestyle factors play an important role in...
Objective To analyse the impact of the COVID-19 pandemic on rheumatic patients’ and rheumatologists’ usage, preferences and perception of digital health applications (DHAs). Methods A web-based national survey was developed by the Working Group Young...
Background: Mobile Health (mHealth) defines the support and practice of health care using mobile devices and promises to improve the current treatment situation of patients with chronic diseases. Little is known about mHealth usage and digital preferences of patients...
The talk will describe our national smartphone study Cloudy with a Chance of Pain, exploring aspects of its set-up, recruitment and retention, analysis and public engagement. For thousands of years, there has been a belief by people living with long-term...
The increasing use of smartphones is accompanied by a significant increase in the use of mobile applications (apps). Chronically ill patients could permanently profit from this development.This development is fuelled by the Digital Healthcare Act (DVG), whereby...